Clinical Trial Update: The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and mechanism of fecal microbiota transplantation for treating ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Jun Liu | Conditions: Ulcerative Colitis, Fecal Microbiota Transplantation | Phase 2, Phase 3 | Status: UNKNOWN